Related Experiment Video
Updated: Aug 23, 2025

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
Published on: July 1, 2020
Mendelian randomization and pathway analysis demonstrate shared genetic associations between lupus and coronary
Jessica Kain1, Katherine A Owen1, Miranda C Marion2
1AMPEL BioSolutions, LLC, Charlottesville, VA, USA; The RILITE Research Institute, Charlottesville, VA, USA.
Insights
Systemic lupus erythematosus (SLE) significantly increases the risk of coronary artery disease (CAD). This study used genetic analysis to identify causal pathways, revealing therapeutic targets for managing CAD in SLE patients.
Area of Science:
- Genetics
- Immunology
- Cardiology
Background:
- Coronary artery disease (CAD) is a primary cause of mortality in patients with systemic lupus erythematosus (SLE).
- Existing genetic studies on the association between SLE and CAD are limited, focusing on a few common risk loci.
- There is a need for comprehensive genetic analyses to understand the pleiotropic effects influencing both conditions.
Purpose of the Study:
- To investigate the causal genetic links between SLE and CAD using advanced Mendelian randomization (MR) techniques.
- To identify specific biological pathways and networks implicated in the co-occurrence of SLE and CAD.
- To uncover potential therapeutic targets for mitigating CAD risk in SLE patients.
Main Methods:
- Employed traditional Mendelian randomization (MR) to estimate the causal effect of SLE-associated SNPs on CAD.
- Utilized SNP-to-gene mapping and protein-protein interaction (PPI) network analysis for pathway identification.
- Applied a PPI-based MR approach using functional gene sets as instrumental variables to confirm causal effects.
Main Results:
- Identified a net positive causal estimate of SLE-associated non-HLA SNPs on CAD.
- Discovered distinct biological networks with both positive and negative causal gene sets connecting SLE and CAD.
- Confirmed the causal influence of specific SNP-to-gene modules on CAD risk.
Conclusions:
- The study elucidates molecular pathways causally linking SLE and CAD.
- Identified biological pathways likely contributing to both diseases, offering insights into shared pathogenesis.
- Revealed potential novel and existing therapeutic strategies for managing CAD in the context of SLE.
Abstract:
Coronary artery disease (CAD) is a leading cause of death in patients with systemic lupus erythematosus (SLE). Despite clinical evidence supporting an association between SLE and CAD, pleiotropy-adjusted genetic association studies are limited and focus on only a few common risk loci. Here, we identify a net positive causal estimate of SLE-associated non-HLA SNPs on CAD by traditional Mendelian randomization (MR) approaches. Pathway analysis using SNP-to-gene mapping followed by unsupervised clustering based on protein-protein interactions (PPIs) identifies biological networks composed of positive and negative causal sets of genes. In addition, we confirm the casual effects of specific SNP-to-gene modules on CAD using only SNP mapping to each PPI-defined functional gene set as instrumental variables. This PPI-based MR approach elucidates various molecular pathways with causal implications between SLE and CAD and identifies biological pathways likely causative of both pathologies, revealing known and novel therapeutic interventions for managing CAD in SLE.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
08:27Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Single Nucleotide Polymorphisms-SNPs
The JAK-STAT Signaling Pathway
Pleiotropy